The outbreak of the pandemic led to huge disruptions in the manufacturing of syringes, which in turn led to supply shortage globally

By -

 Increase in demand for injectable drug delivery devices across the globe and rise in incidence of chronic diseases act as the major driving forces for the global syringes market. Furthermore, increase in demand for technologically advanced syringes notably contribute toward the growth of the market.

The global syringes market size was valued at $15,340 million in 2019, and is projected to reach $32,394.74 million by 2027, growing at a CAGR of 9.6% from 2020 to 2027.

Upsurge in incidence of needle stick injuries, rise in awareness about smart syringes, and high-end technological advancements fuel the growth of the global syringes market. On the other hand, high cost and unaffordability of safety syringes and alternative modes of drug delivery impede the growth to some extent. However, increase in need for safety syringes in emerging economies is expected to create lucrative opportunities in the industry.

Covid-19 scenario-

  • The outbreak of the pandemic led to huge disruptions in the manufacturing of syringes, which in turn led to supply shortage globally.
  • However, the lockdown has now loosened off and the global syringes market is expected to recoup really soon.

The specialized syringes segment to dominate by 2027-

Based on product, the specialized syringes segment accounted for more than two-thirds of the global syringes market share in 2019, and is projected to maintain the lion’s share by the end of 2027. The same segment would also register the fastest CAGR of 10.0% from 2020 to 2027. Surge in use of disposable syringes and rise in demand for injectable drugs drive the growth of the segment.

The disposable syringes segment to lead the trail-

Based on usage, the disposable syringes segment contributed to 90% of the global syringes market revenue in 2019, and is expected to rule the roost by 2027. The same segment would also manifest the fastest CAGR of 9.8% throughout the forecast period. This is attributed to its role in reducing the risk of infection, which is high while using reusable syringes, and economical costs as compared to reusable syringes

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/7879

North America had the major share in 2019-

Based on geography, North America held the major share in 2019, garnering more than two-fifths of the global syringes market. This is due to increase in demand for advanced syringes, availability of well-developed healthcare infrastructure, and presence of major giants in the region. Simultaneously, the market across Asia-Pacific would exhibit the fastest CAGR of 10.8% from 2020 to 2027, owing to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, development of the R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare.

Frontrunners in the industry-

  • B. Braun Melsungen AG
  • Becton
  • Dickinson and Company
  • Cardinal Health Inc
  • Gerresheimer AG
  • Hindustan Syringes and Medical Devices Ltd.
  • Medline Industries, Inc
  • Nipro Corporation (Nipro Medical Corporation)
  • Retractable Technologies, Inc
  • Smith’s Group Plc
  • Terumo Corporation (Terumo Medical Corporation)

Comments

Post a Comment

Popular posts from this blog

Global Cancer pain market is segmented based on drug type, disease indication, and region.

By -
According to a new report published by Allied Market Research, titled, "Cancer Pain Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"  the global cancer pain market was valued at $5,285 million in 2017, and is expected to reach $7,545 million by 2025, growing at a CAGR of 4.5% from 2018 to 2025. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/5123?utm_source=Blogger&utm_medium=Niranjan Cancer pain is chronic in nature and is commonly associated with cancer. It results from tissue damage, either due to the disease itself or due to different treatments such as chemotherapy, radiotherapy, or surgery. Cancer pain drugs are expected to exhibit significant market growth during the forecast period due to growth in demand for the drugs, surge in prevalence of cancer across the globe, increase in number of R&D activities to develop ideal cancer pain medications, and rise in the unmet nee...
Read more

U.S. was the largest country market in 2015, and is projected to maintain its lead until 2022.

By -
Image
  Surge in usage of wireless monitoring devices and increase in population of aging people across the globe drive the growth of the global patient monitoring devices market. However, high cost associated with patient monitoring devices is anticipated to restrain the market growth. Furthermore, increasing technological advancements are expected to provide new opportunities during the forecast period. The  Patient Monitoring Devices Market  generated $25.76 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.4% from 2020 to 2027. Based on product type, the cardiac monitoring devices segment contributed to the largest share in 2019, accounting for more than one-fourth of the total share, and is estimated to maintain its dominant position during the forecast period. However, the remote patient monitoring devices segment is estimated to portray the highest CAGR of 6.3% during the forecast period. Based on end-user, the hospitals segment a...
Read more